medigraphic.com
ISSN 2992-8036 (Digital)
ISSN 2306-4102 (Impreso)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2012, Número 5

<< Anterior

Acta Ortop Mex 2012; 26 (5)


Bancos de tejidos musculoesqueléticos en México: conducta, manejo y recomendaciones sobre sus actividades

Álvarez-San Martín R

Idioma: Español
Referencias bibliográficas: 41
Paginas: 332-339
Archivo PDF: 69.80 Kb.


RESUMEN

Actualmente, los bancos de tejidos requieren de un manejo interdisciplinario que obliga a detectar y resolver sus conflictos de presión, tomando en cuenta las consideraciones éticas, la seguridad y la calidad de los tejidos provistos, su conducta bajo los principios de altruismo, solidaridad y equidad así la obtención de tejidos del donante cadavérico. Este artículo de revisión tiene como por objetivo informar acerca de los principales aspectos de trabajo y coordinación de los departamentos propios de los bancos de tejidos, reconocer sus figuras de responsabilidad sanitaria y los organismos que emiten recomendaciones para mantener la seguridad clínica respecto a la prevención de las infecciones y transmisión de las enfermedades relacionadas con los injertos musculoesqueléticos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ethical Aspects of Human Tissue Banking: Opinion of the European Group on Ethics in Science and New Technologies to the European Comission, 1998.

  2. Fehily D, Dziedzic-Goclawska A, Kaminski A: Module 5. Quality assurance-quality control. Subject 1. Tissue banking: general organization. International On-Line Tissue Banking Course 2010; IL3.

  3. Convention for the Protection of Human Rights and dignity of the Human Being with Regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. Article 1 Council of Europe, 1997.

  4. Schulz-Baldes A, Biller-Adorno N, Capron AM: International perspectives on ethics and regulation of human cell and tissue transplantation. Bulletin of the World Health Organization 2007; 85: 941-8.

  5. Explanatory Report of the Additional Protocol to the convention for Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine Concerning Transplantation of Organs and Tissues of Human Origin. 1997: 123.

  6. U.S. Department of Health and Human Services. Food and Drug Administration: Guidance for Industry. Elegibility Determination for Donors of Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/Ps). Center for Biologics Evaluation and Research; 2007.

  7. Directive 2004/23/EC of the European Parliament and of the Council of 31 march 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Official Journal L 2004; 102,7.4: 48-58.

  8. Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23 as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. Official Journal L 2006; 38/40,9.2.

  9. Directive 2006/86/EC of 24 October 2006 implementing Directive 2004/23 as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells. Official Journal L 2006; 294/32.

  10. International Organization for Standardization [Internet]. ISO standards [última consulta: 2012, Enero 3]. Available in: http://www.iso.org/iso/iso_catalogue/management_and_leadership_standards/quality_management/iso_9000_essentials.htm.

  11. European Directive 2004/23/EC Chapter IV. Provisions on the quality and safety of tissues and cells. Article 16, Quality Management. Tissue and Cell Directive– Directive 2004/23/EC of the European Parliament and the Council of 31 March 2004 on setting standards of the quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissue and cells. Official Journal of the European Union L.102/55.

  12. Ley General de Salud Título XIV, Capítulo I: Disposiciones Comunes. Artículo 316 (DOF11-06-2009).

  13. European Directive 2004/23/EC Chapter IV. Provisions on the quality and safety of tissues and cells. Article 17, Responsible Person. Tissue and Cell Directive – Directive 2004/23/EC of the European Parliament and the Council of 31 March 2004 on setting standards of the quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissue and cells. Official Journal of the European Union L.102/55.

  14. Reglamento de Insumos Título Cuarto Establecimientos. Capítulo III: Responsables Sanitarios (últimas reformas DOF 5-08-2008).

  15. Ley General de Salud Título XIV Donación, Trasplantes y Pérdida de la Vida. Capítulo I: Disposiciones Comunes, Artículo 315 (últimas reformas DOF 11-06.2009).

  16. Ley General de Salud Título XIV Donación, Trasplantes y Pérdida de la Vida. Capítulo I: Disposiciones Comunes, Artículo 316 (últimas reformas DOF 11-06.2009).

  17. European Directive 2004/23/EC Chapter IV. Provisions on the quality and safety of tissues and cells. Article 24, Relations between tissue establishment and third parties. Tissue and Cell Directive– Directive 2004/23/EC of the European Parliament and the Council of 31 March 2004 on setting standards of the quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissue and cells. Official Journal of the European Union L.102/56.

  18. Ley General de Salud Título XIV: Donación, Trasplantes y Pérdida de la Vida. Capítulo III: Trasplante, Artículo 337 (últimas reformas DOF 11-06.2009).

  19. Álvarez SMR: Los tejidos musculoesqueléticos con fines de trasplante en México. Análisis de la organización, regulación y manejo del banco de tejidos hospitalario y las recomendaciones sobre la disposición de tejidos musculoesqueléticos considerados como insumos para la salud. [Tesina del Diplomado de Coordinación de Donación de Órganos y Tejidos con Fines de Trasplante]. México, D.F. Centro Nacional de Trasplantes, CENATRA-Universidad Nacional Autónoma de México, UNAM; 2010.

  20. Transplant Services Foundation (TSF): Quiénes somos. Servicio Coordinación de Trasplantes. Disponible en: www.tsf.cat

  21. Joyce MJ, Greenwald AS, Boden S, et al: Musculoskeletal tissue allograft safety. Committee on Biological Tissue Implants Working Group. AAOS 75th Annual Meeting., San Francisco California; 2008.

  22. Centers for Disease Control and Prevention: About tissue transplants 2006 [Internet]. Available in: http://www.cdc.gov/ncidod/dhqp/tissueTransplantsFAQ.html.

  23. Nemzek JA, Swenson CL, Arnoczky SP: Retroviral transmission by the transplantation of connective tissue allografts. An experimental study. J Bone Joint Surg Am 1994; 76: 1036-41.

  24. Vangsness CT Jr, García IA, Mills CR, et al: Allograft transplantation in the knee: tissue regulation, procurement, processing, and sterilization. Am J Sports Med 2003; 31: 474-81.

  25. AOSSM 2006: Orthopaedic surgical procedure survey on allografts. naperville (IL). Leever Research Services; 2006.

  26. McAllister DR, Joyce MJ, Mann BJ, et al: Allograft update: the current status of tissue regulation, procurement, processing and sterilization. Am J Sports Med 2007; 35(12): 2148-58.

  27. Centers for Disease Control and Prevention (CDC): Epidemiologic notes and reports transmission of HIV through bone transplantation: case report and public health recommendations. MMWR Morb Mortal Wkly Rep 1988; 37(39): 597-9.

  28. Asselmeier MA, Caspari RB, Bottenfield S: A review of allograft processing and sterilization techniques and their role in transmission of the human immunodeficiency virus. Am J Sports Med 1993; 21: 170-5.

  29. Simonds RJ, Holmberg SD, Hurwitz RL, et al: Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992; 326: 726-32.

  30. Simonds RJ: HIV transmission by organ and tissue transplantation. AIDS 1993; 7(Suppl 2): S35-8.

  31. Li CM, Ho YR, Liu YC: Transmission of human immunodeficiency virus through bone transplantation: a case report. J Formos Med Assoc 2001; 100(5): 350-1.

  32. Sanzen L, Carlsson A: Transmission of human T-cell lymphotrophic virus type 1 by a deep-frozen bone allograft. Acta Orthop Scand 1997; 68: 72-4.

  33. Centers for Disease Control and Prevention (CDC): Hepatitis C virus transmission from an antibody-negative organ and tissue donor–United States, 2000-2002. MMWR Morb Mortal Wkly Rep 2003; 52: 273-4, 276.

  34. Septic arthritis following anterior cruciate ligament reconstruction using tendon allografts– Florida and Louisiana, 2000. Morb Mortal Wkly Rep 2001; 50(48): 81-3.

  35. Centers for Disease Control and Prevention (CDC): Update: Allograft-associated bacterial infections-United States, 2002. MMWR Morb Mortal Wkly Rep 2002; (51): 207-10.

  36. Centers for Disease Control and Prevention (CDC): Invasive Streptococcus pyogenes after allograft implantation– Colorado, 2003. MMWR Morb Mortal Wkly Rep 2003; (52): 1173-6.

  37. Barriga A, Díaz-de Rada P, Barroso JL, et al: Frozen cancellous bone allografts: positive cultures of implanted grafts in posterior fusions of the spine. Europ Spine J 2004; 13(2): 152-6.

  38. Martínez-Pardo M, Hernández L, Reyes-Frías M, Luna Zaragoza D: Coding and Traceability used by tissue Banks in Mexico. Cell Tiss Bank 2010; 11(4): 393-5.

  39. Kalter ES: Tissue banking programmes in Europe. Brit Med Bull 1997; 53(4): 798-816.

  40. Alabat: Taller de buenas prácticas en procesamiento y producción en bancos de tejidos. Proyecto RLA/6/062 ARCAL CVIII. Anexo III. Disponible en: http://www.alabat.org/index.php?option=com_content&view=section&layout=blog&id=9&Itemid=72

  41. Organización Mundial de la Salud: Consejo Ejecutivo de la CXXIIIª Reunión. Anexo del documento EB123/5. Principios rectores de la OMS sobre trasplante de células, tejidos y órganos humanos; 2008.




2020     |     www.medigraphic.com